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Abstract
Purpose The caregiver roles and responsibilities scale (CRRS) was developed to facilitate formal assessment of broad life 
impacts for informal (i.e. unpaid) caregivers to people with cancer. Here we report the development and initial validation.
Methods The CRRS was developed from the thematic analysis of two interview studies with cancer patients (stage III-IV 
breast, gynaecological, lung or melanoma) and caregivers. In the evaluation studies, participants completed the CRRS along-
side the Caregiver Quality of Life—Cancer, the main criterion measure for concurrent validity, and the WHOQOL-BREF 
for additional convergent validity data. Questionnaires were completed at baseline, 7-days and 2-months. Demographic data 
and patient characteristics were collected at baseline.
Results Two-hundred and forty-five caregivers to people with stage I-IV breast, colorectal, gynaecological, head and neck, 
lung or renal cancer or melanoma completed the CRRS at least once. The final 41 core items selected comprised five sub-
scales: Support and Impact, Lifestyle, Emotional Health and Wellbeing, Self-care and Financial Wellbeing as well as three 
standalone items. Missing data rate was low (0.6%); there were no ceiling or floor effects for total scores. Cronbach’s alpha 
was 0.92 for the CRRS-41; 0.75–0.87 for the subscales. CRRS showed good test–retest reliability (ICC = 0.91), sensitivity 
to change and the predicted pattern of correlation with validation measures r = 0.75–0.89. The standalone 7-item jobs and 
careers subscale requires further validation.
Conclusions Initial evaluation shows the CRRS has good validity and reliability and is a promising tool for the assessment 
of the effects of cancer and cancer treatment on the lives and wellbeing of informal caregivers.
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Background
Informal (i.e. unpaid) caregivers of patients, such as spouses, 
family members or friends, frequently provide significant 
amounts of care and support [1, 2] often alongside their 
many other responsibilities [3–6]. Informal caregiving 
contributes to patients’ overall experiences of treatment, 
therefore maintaining their wellbeing and satisfaction is 
essential [1, 2].
Caregivers must manage several factors relating directly 
to a patient’s illness together with other ‘secondary stressors’ 
[4] such as changing roles, disruption to lifestyle and fam-
ily functioning, changes to relationships and sense of self, 
concerns regarding their own and the patient’s employment 
with the associated financial implications [4]. Additionally 
informal caregivers may also be caring for children and/or 
other family members, which can complicate and compound 
the more negative aspects and effects of being a primary car-
egiver to someone with cancer [3, 7, 8]. Informal caregivers 
play a crucial role, yet formal assessment of the effects on 
their lives and wellbeing is not routine.
Our systematic review [9] revealed that few of the meas-
ures used for caregiver quality of life and caregiver burden 
were developed and validated specifically in the cancer car-
egiver population. In addition, most were developed a long 
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time ago, when the advances in medicine that now allow 
so many patients to live with cancer as a chronic condi-
tion, and the associated adaptations required to their own 
and their family’s lives, had not been made. We found nota-
ble gaps in item coverage in a concept mapping exercise to 
examine the content of these measures. Results suggested 
that currently available scales do not capture adequately 
changes in occupational, financial, household and fam-
ily roles and responsibilities as a result of caregiving, or 
the broader impacts on the family unit. The influence on 
career aspiration and progression were not addressed at all; 
for example, the opportunity cost of a missed promotion at 
work [9]. Caregivers experience a sense that their own life 
is suspended, ‘on hold’ in some way; that the uncertainty 
around the length and quality of the patient’s survival affects 
wide-ranging areas of life [10–13]. It is vital that this lack 
of control and altered sense of agency is better captured in 
caregiver outcome measures.
Our systematic reviews of Patient Reported Outcome 
Measures in use in the cancer patient [14] and cancer car-
egiver [9] populations highlighted the need for new rigor-
ously developed, well-validated quality of life measures to 
assess these broader impacts of disease and treatment.
Overview
The PROACT (Patient Reported Outcomes, impact of Age 
and Carer role demands associated with Treatment) pro-
gramme of work is a multi-phase project, informed by the 
Quality of Survival (QoS) concept framework [15]. The 
measures were developed to be used alongside the Func-
tional Assessment of Chronic Illness Therapy (FACIT) 
measurement system and are intended to capture the broader 
impact of cancer and its treatment during the evaluation of 
new treatments in clinical trials. Results from questionnaire 
completion might also enable discussions between clini-
cians, patients and caregivers about potential treatments and 
supportive interventions.
Previously we described the development and initial 
validation of the Patient Roles and Responsibilities Scale 
(PRRS) [16]. This paper reports the four studies that com-
prised the development and evaluation of the Caregiver 
Roles and Responsibilities Scale (CRRS). The initial devel-
opment studies were conducted with caregivers to people 
with stage III-IV cancer. This was to reflect the fact that due 
to scientific advances, there has been a large increase in the 
number of patients living with their cancer, rather than being 
cured of it, while trying to maintain ‘normal’ life including 
family, financial and employment responsibilities. These 
aspects of life are significantly impacted for caregivers as 
well as patients and we wanted to ensure the measure cap-
tured these. The measure was, however, developed with the 
intention to be appropriate for caregivers to patients with any 
stage or type of cancer and the later validation study includes 
caregivers to patients with stage I-II cancer.
Ethics statement
Studies 1–3 received ethics approval from London Queen 
Square Research Ethics Committee (ref: 15/LO/1323; 14th 
September 2015 and ref: 16/LO/1125; 6th September 2016). 
Study 4 received ethics approval from London Central 
Research Ethics Committee (ref: 17/LO/1773; 12th Octo-
ber 2017). Signed informed consent was obtained from all 
participants.
Eligibility criteria
Inclusion/exclusion criteria were broadly the same across 
all four studies. Eligible patients had advanced (stage III/
IV) lung cancer, gynaecological cancer or melanoma. For 
studies 1 and 2, we required that patients nominate an infor-
mal caregiver also willing to take part. Both cohorts were 
required to be over 18 years of age, have capacity to give 
informed consent and be able to read and speak in Eng-
lish (essential for the purposes of scale development and 
evaluation). Individuals who were inpatients or acutely dis-
tressed for any reason were excluded. In studies 2 and 3 
we expanded the patient population to include women with 
breast cancer. In study 3 we relaxed the requirement that 
both patient and caregiver consent to the study; either party 
could participate alone. In study 4 we expanded the popula-
tion further to include patients with renal, head and neck 
and colorectal cancer and those whose cancer was stage I/
II. This is because the questionnaire has been developed to 
be suitable for use by people supporting patients with cancer 
of all types and stages.
Scale development: studies 1 and 2
Study 1: item generation
We conducted in depth qualitative interviews with 24 
patients with advanced cancer and their nominated informal 
caregivers (N = 23) about the influence of extended cancer 
survival on broader aspects of life and wellbeing (see sup-
plementary file S1 for participant demographics). Interviews 
were recorded and transcribed verbatim.
A thematic framework was developed from an initial pro-
cess of open coding and tested iteratively as new data were 
collected. Thematic analysis identified 20 themes and 33 
sub-themes from which a list of 181 potential items was 
generated for the caregiver scale. These were reviewed for 
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relevance and redundancy by the authors before 51 potential 
items were viewed by our panel of advisors. 64 items were 
retained for evaluation in Study 2. The Caregivers Roles 
and Responsibilities Scale will sit within the FACIT meas-
urement system. As such, when concepts were identified 
that were important to caregivers, we checked if existing 
items within the FACIT library were appropriate rather than 
generating new items; those items being already validated 
measures of the concept. It would be unnecessary and even 
inappropriate to generate new items on the same content 
when fully validated (and often translated into multiple 
languages) items exist within the measurement system that 
the CRRS will be part of. With permission, we included 3 
items from the FACIT Comprehensive Score for Financial 
Toxicity (COST) measure [17], 3 items from the Functional 
Assessment of Cancer Therapy-General (FACT-G) [18] and 
1 item from FACIT-Spirituality (FACIT-Sp) [19]. For fur-
ther detail on the procedure and analysis of these interviews, 
see the related open access paper [16].
Study 2: item reduction and scale construction
Cognitive interviews were conducted with a new cohort of 
20 patients and their informal caregivers using a mixture 
of the ‘think aloud’ technique and specific probes around 
comprehension, retrieval, judgement and response options 
to assess each of the potential scale items. Items were also 
discussed in terms of acceptability, relevance, redundancy 
and importance. Participants were also given the opportunity 
to identify missing topics. See supplementary file S1 for 
participant demographics.
Scale items were revised, added and removed in an itera-
tive fashion through the course of the study. Ninety-four 
changes were made to the caregiver scale including 80 word-
ing revisions, 9 deletions and 5 additions resulting in a 60 
item scale. In order to present the questionnaire in manage-
able ‘chunks’ for the participant we loosely grouped items 
under the headings: Family and Support (N = 12); Relation-
ships and Communication (N = 7); Lifestyle and Outlook 
(N = 12); Health and Wellbeing (N = 14); Financial Wellbe-
ing (N = 6) and Jobs and Careers (N = 9). We did not theorise 
that these groupings necessarily reflect the underlying factor 
structure.
Evaluation and validation: studies 3 and 4
Studies 3 and 4 were conducted consecutively. In study 3, 
participants completed the full 60 item CRRS as described 
below. CRRS individual item data were then analysed for the 
purpose of item reduction. Participants in study 4 completed 
the reduced CRRS. Data from the reduced CRRS from both 
studies were analysed together for the Exploratory Factor 
Analysis, test retest reliability, criterion and convergent 
validity and sensitivity to change.
Methods
Population and procedure
Study 3 participants were recruited from 11 sites in England. 
Participants were the informal caregivers to patients with 
stage III/IV breast, gynaecological or lung cancer or malig-
nant melanoma. Study 4 participants were recruited from 13 
sites in England. Participants were the informal caregivers to 
patients with stage I-IV breast, colorectal, gynaecological, 
head and neck, lung or renal cancer or malignant melanoma.
Participants completed questionnaires at home either on 
paper or online, whichever their preference. Participants 
completing online were not forced to respond to all items, 
although an onscreen message notified them of omissions. 
Where participants missed multiple items, whether complet-
ing on paper or online, they were followed up by the study 
team to determine whether the omissions were intentional 
or if they had skipped them accidentally (with the option to 
provide a response at this point). Demographics and the full 
validation pack were completed at baseline, the CRRS was 
completed alone after 7 days (for test–retest) and the full 
pack completed again after 2 months (sensitivity to change).
Measures
Participants completed the CRRS alongside a validation bat-
tery including the WHOQOL-BREF [20] and the Caregiver 
Quality of Life—Cancer [21]. They provided basic demo-
graphic information such as age, employment status, level 
of education, relationship status, caregiving responsibilities 
and information regarding the diagnosis and treatment of the 
person they support.
The CRRS
The CRRS as completed in Study 3 comprised 60 items: 51 
Core Items formatted for the FACIT measurement system 
(responses as item applies to the past 7 days, 5 response 
options ranging from Not at All—Very Much) and 1 binary 
response item on whether the participant has stopped work 
due to their caregiving responsibilities. A standalone scale, 
Jobs and Careers comprising 2 binary response items and 
7 Likert-scale items is completed only by participants cur-
rently in paid employment. Negatively worded items were 
reverse scored so that a higher score corresponds to bet-
ter Quality of Life. Participants in Study 4 completed the 
reduced CRRS with 41 Core Items and the Jobs and Careers 
subscale.
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The WHOQOL‑BREF [20]
The WHOQOL-BREF is a 26 item scale that produces 
a quality of life profile with four domain scores (physi-
cal health, psychological health, social relationships and 
environment) and two individually scored items about an 
individual’s overall perception of quality of life and health. 
Each item is rated on a 5 point scale (scored 1–5). The four 
domain scores are scaled in a positive direction with higher 
scores indicating a higher quality of life.
The caregiver quality of life cancer scale (CQOLC) [21]
The CQOLC is a well-validated and extensively used qual-
ity of life measure developed specifically for caregivers of 
people with cancer. It has 35 items rated on a five point scale 
(not at all—very much). Scores range from 0 to 140 with 
higher scores indicating higher quality of life. It comprises 
domains relating to burden, disruptiveness, finances and pos-
itive adaptation. Our recent systematic review [22] found the 
CQOLC, alongside the Caregiver Reaction Assessment [23] 
had the strongest support for its psychometric performance.
Data analysis
Analyses were conducted using the Statistical Package for 
Social Sciences (IBM SPSS; version25). Missing data from 
CRRS, although rare, were managed by prorating the total 
for selected analyses. Missing data from other questionnaires 
were managed as per the specific instrument guidance. We 
used guidelines from the International Society for Pharma-
coeconomics and Outcomes Research (ISPOR) [24, 25] and 
COSMIN (Consensus-based Standards for the Selection of 
Health Measurement Instruments) [26] in the development 
and evaluation of this measure.
On the completion of Study 3, the CRRS was assessed in 
terms of acceptability (missing data, time to complete) and 
precision (floor/ceiling effects, skewness, inter-item correla-
tions) and a number of items removed.
Combined data from Study 3 and 4 were then analysed 
using Exploratory Factor Analysis (PCA with oblique rota-
tion); internal consistency (Cronbach’s alpha); criterion 
and convergent validity (correlation); test–retest reliability 
(Intraclass Correlation, two-way random, absolute agree-
ment; weighted Kappa for individual items) and responsive-
ness to change (caregivers were categorised as improved, 
worsened or unchanged based on meaningful change in 
WHOQOL-BREF. Paired t-tests were used to determine 
if CRRS change within a group was significantly different 
from zero. Spearman correlation coefficients were calculated 
to explore the relationship between change on PRRS and 
change on WHOQOL-BREF and CQOLC). Data analysis 
methods, including thresholds, are explained in greater detail 
in the related open access paper [16].
Results study 3
Participants
Of the 119 caregivers who consented to take part, 110 com-
pleted baseline assessment (29 caregivers to patients with 
breast cancer, 31 gynaecological, 31 lung and 19 mela-
noma), 103 completed T2 and 96 completed T3. At baseline, 
age ranged from 18 to 88 (median 60 years); 57% were male. 
Relationship to patient was: partner/spouse (N = 83, 75%); 
child of patient (N = 14, 13%); friend (N = 5, 4%); sibling 
(N = 4, 4%) parent of patient (N = 2, 2%) and ‘other’ (N = 2, 
2%).
Acceptability and precision of CRRS
Missing data rates for the CRRS were extremely low; 0.3% 
at baseline, 0.1% at Time 2 and 0.1% at Time 3. Missing 
data were distributed across 11 of the 58 Likert-scale items 
at baseline, 8 items at Time 2 and 5 at Time 3 with no single 
item having more than 2 missing responses at any time point. 
We had set a threshold that items with > 15% missing data 
would be investigated for acceptability. The highest rate of 
missing data for a single item at any time point was 4% to 
an employment question with 45 responses of a possible 47; 
for core questions with the larger sample, the highest rate 
of missing data for a single item at any time point was 2%.
At baseline, 62 participants completed questionnaires 
online, 48 completed on paper, but only 43 recorded the 
time taken to complete the CRRS. Time to complete online 
ranged from 2.9 to 20.6  min with 1 extreme outlier at 
34.4 min (mean excluding outlier = 9.3 min, SD = 4.0 min). 
On paper, time to complete ranged from 8 to 25 min, (exclud-
ing outliers above the 90th percentile), mean = 13.2 min, 
SD = 4.5 min.
CRRS core items: item reduction
None of the individual items had missing data > 15%. Scores 
of minimum ‘0’ ranged from 0.9 to 90.9%; on 42/51 items 
less than 20% of responses were the minimum ‘0’. 1 item 
had floor effects exceeding 70% (90.9%—‘I take part in sup-
port groups and/or internet forums’).
Four items showed above threshold ceiling effects (72.7% 
‘My caregiving responsibilities are a burden’ [reverse 
scored]; 77.8% ‘I feel appreciated by X’; 79.1% ‘I have dif-
ficulty meeting the additional costs of supporting X’ [reverse 
scored]; 83.6% ‘I feel close to X’). Scores of maximum ‘4’ 
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ranged from 0.9 to 83.6%; 15/51 items had 20% or less 
responses at maximum ‘4.
Eleven items had an unacceptably low level of correla-
tion with other items and low (< 0.3) corrected item-total 
correlations in reliability analysis and concerns around face 
validity. In addition five of these did not meet the meas-
ure of sampling adequacy (set at 0.7). Ten of the eleven 
were removed from further analysis including the item with 
above threshold floor effects and 2 of the 4 items with above 
threshold ceiling effects. The item Sp9 was retained because 
it was felt important to keep an item pertaining to spiritual 
wellbeing.
Of the 41 retained Likert-scale core items, 14 had 
z-score of skewness > ǀ4ǀ however their performance in 
terms of relationship to other items, corrected item-total 
correlation and/or conceptual significance to the measure 
ensured their retention at this stage. Total scores on the 
modified CRRS Core-41 (N = 110) ranged from 33 to 148 
(possible range 0-164), mean = 105.56, SD = 23.48 with 
skewness = − 0.73(SE = 0.23).
Results study 3 and 4
Participants
Of the 269 caregivers who consented to take part, 245 com-
pleted baseline assessment (59 caregivers to patients with 
lung cancer, 57 gynaecological, 43 breast, 38 melanoma, 
19 colorectal, 17 renal and 12 head and neck), 227 com-
pleted T2 and 211 completed T3. At baseline, age ranged 
from 18 to 89 (median 60 years); 52% were male. Relation-
ship to patient was: partner/spouse (N = 192, 78%); child of 
patient (N = 22, 9%); friend (N = 12, 5%); sibling (N = 8, 3%) 
parent of patient (N = 8, 3%) and ‘other’ (N = 3, 1%). See 
Fig. 1 for full details of caregivers approached, consented 
and completed questionnaires at each time point, along with 
reasons for decline/drop out and Table 1 for key participant 
characteristics.
Missing data rates for the CRRS were very low: 0.6% 
at baseline; 0.4% at Time 2 and 0.4% at Time 3. Missing 
data were distributed across 27 of the 48 Likert-scale items 
at baseline; in the majority of cases with only one or two 
missing responses from 245 participants. Three items in 
particular had higher missing data rates of 10 (4%), 8 (3%) 
and 5 (2%). Missing data at T2 were distributed across 22/48 
items. Two of the same items again had higher rates of miss-
ing data with 8 (4%) and 6 (3%) missing responses. At T3 
missing data were distributed across 22/48 items.
We had set a threshold that items with > 15% missing 
data would be investigated for acceptability. While none of 
the items had missing data close to this level, the three items 
identified also showed a very low pattern of correlation with 
other items (r < 0.3) and low corrected item-total correla-
tions in reliability analysis. As such, they were not included 
in the exploratory factor analysis and do not sit within the 
subscales identified therein. They do however cover impor-
tant aspects of wellbeing not measured by other items in the 
scale and are retained as standalone items (see Table 2 for 
details).
Exploratory factor analysis
Thirty-eight items were entered into the EFA. Following 
listwise deletion based on all variables, N = 228 (COSMIN 
guidelines [26] consider an item to participant ratio of 1:5 to 
be ‘good’; this ratio is 1:6). Bartlett’s test of sphericity was 
significant at < 0.0001 and the Kaiser–Meyer–Olkin (KMO) 
value was 0.87, confirming that the data were suitable for 
factor analysis. All items had above threshold (> 0.7) MSA 
suggesting adequate communality with other variables.
Nine eigenvalues were greater than 1.0, explaining a total 
of 64.3% of variance. Consideration of the scree plot sug-
gested that 5 factors might be retained explaining 26.9, 8.8, 
6.1, 5.2 and 4.8% of variance respectively (51.8% total vari-
ance). Items and their factor loadings are shown in Table 3. 
Most (33/38) items loaded clearly on one factor; the remain-
ing had loadings < 0.4 on all factors (range 0.33–0.39).
The five factors were labelled and evaluated as potential 
subscales: Emotional Health and Wellbeing (Cronbach’s 
α = 0.87, corrected item-total correlation range 0.33 to 0.72); 
Lifestyle (Cronbach’s α = 0.87, corrected item-total correla-
tion range 0.49 to 0.70); Support and Impact (Cronbach’s 
α = 0.82, corrected item-total correlation range 0.52 to 0.69); 
Self-care (Cronbach’s α = 0.75, corrected item-total corre-
lation range 0.36 to 0.68) and Financial Wellbeing (Cron-
bach’s α = 0.78, corrected item-total correlation range 0.43 
to 0.68) Inter-item and inter-subscale correlations are shown 
in Table 4.
Internal consistency
Cronbach’s α for the CRRS full scale at baseline was 0.92 
(corrected item-total correlation range 0.09–0.65); at T2 
α = 0.94 (CITC range 0.10–0.71) and at T3 α = 0.93 (CITC 
range 0.12–0.71). If the three standalone items are excluded, 
α at baseline was 0.92 (corrected item-total correlation range 
0.24–0.64); at T2 α = 0.94 (CITC range 0.32–0.71) and at T3 
α = 0.93 (CITC range 0.25–0.71).
Criterion and convergent validity
Total scores for participants with full data sets on the 
CRRS Core-41 (N = 219) ranged from 33 to 152 (possi-
ble range 0–164), mean = 108.74, SD = 23.07 with skew-
ness = − 0.58 (SE = 0.16). As predicted, total scores on the 
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Fig. 1  Flow of participants through study
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Table 1  Key caregiver 
characteristics and CRRS-41 
scores
SRRC542=N
(Mean ±SD) 
Univariate P 
Age group 
≤50 
    51-65 
≥66 
68 (27.8%) 
103 (42.0%)
74 (30.2%) 
106.16±25.08 
106.52±23.86 
117.40±18.70 
.003 
Post hoc comparison 
(Bonferroni) old v middle 
p=.006; old v young p = .011
Sex 
    Female 
    Male 
117 (47.8%)
128 (52.2%) 
111.85±23.47 
107.75±22.99 
.169 
Relaonship status 
    Partner 
    No partner 
224 (91.4%)
21 (8.6%) 
109.70±22.87 
109.81±27.69 
.984 
Educaon Study 3b
(missing N=4, valid % presented) 
    Secondary 
    Further 
    University 
    Professional qualificaons 
33 (31.1%) 
20 (18.9%) 
21 (19.8%) 
32 (30.2%) 
109.83 ± 19.23 
103.88 ± 22.47 
102.98 ± 27.81 
104.20 ± 26.35 
.684 
Educaon Study 4b
(missing N=4, valid % presented) 
    Secondary 
    Further 
    University 
64 (48.9%) 
39 (29.8%) 
28 (21.4%) 
116.81± 22.25 
109.51± 24.30 
110.82± 21.28  
.232 
Employment status 
    Rered 
    Employed/self-employed/sick leave 
    Not in paid employment  
89 (36.3%) 
128 (52.2%)
28 (11.4%) 
117.29±19.51 
107.70±22.98 
94.77±26.93 
<0.001 
Bonferroni rered v not 
employed p<.001; rered v 
employed p = .006; employed v 
not employed p=.018
Stopped work due to caregiving 
(missing N=7, valid % presented) 
    Yes 
    No 
23 (9.7%) 
215 (90.3%) 
91.77±28.13 
111.66±21.96 
<.001 
Relaonship to paent 
    Spouse/partner 
    Child 
    Parent 
    Sibling 
    Friend 
    Other 
192 (78.4%)
22 (9.0%) 
8 (3.3%) 
8 (3.3%) 
12 (4.9%) 
3 (1.2%) 
108.54±23.23 
115.64±19.46 
112.73±25.61 
.297 
Caring for a person with 
    Lung  
    Gynaecological  
    Breast 
    Melanoma 
    Colorectal 
    Renal 
    Head & Neck 
59 (24.1%) 
57 (23.3%) 
43 (17.6%) 
38 (15.5%) 
 19  (7.8%) 
 17  (6.9%) 
 12  (4.9%) 
106.54±22.46 
106.34±20.35 
107.89±25.81 
115.13±26.38 
115.91±19.85 
113.23±24.73 
115.84±21.48 
.304 
Caring for a person on treatment 
(missing N=21, valid % presented) 
    Yes 
    No 
140 (62.5%)
84 (39.5%) 
107.47±23.43 
114.67±23.47 
.027 
Caring for a person diagnosed 
    <1 year ago 
    1-2 years ago 
    >2yrs ago 
99 (40.4%) 
46 (18.8%) 
100 (40.8%) 
110.61±22.71 
113.42±23.32 
107.11±23.70 
.278 
Other caregiving responsibilies 
    Yes 
    No 
159 (64.9%)
86 (35.1%) 
108.40±22.16 
112.12±25.13 
.233 
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CRRS correlated strongly with scores on the gold standard 
measure, the Caregiver Quality of Life—Cancer (r = 0.89, 
N = 217) and the other validation measure the WHOQOL-
BREF (r = 0.75, N = 214).
Removing the three standalone items from the total score 
results in a range from 32 to 148 (possible range 0–152), 
N = 228, mean = 103.04, SD = 22.39 with skewness = − 0.60 
(SE = 0.16) correlating with CQOLC (r = 0.88, N = 226) and 
WHOQOL-BREF (r = 0.74, N = 223).
Test–retest reliability
The median number of days between baseline and T2 was 9 
(range 4–26). Two participants were excluded from analysis 
as T2 was completed too far from baseline. Total CRRS 
scores showed good test–retest reliability (two-way random, 
absolute agreement) (ICC = 0.91, 95% CI 0.88–0.93) as did 
the five potential subscales: Emotional health and wellbe-
ing (ICC = 0.85, 95% CI 0.81–0.89); Lifestyle (ICC = 0.86, 
95% CI 0.82–0.89); Support and impact (ICC = 0.77, 95% 
CI 0.71–0.82); Self-care (ICC = 0.79, 95% CI 0.73–0.84) 
and Financial Wellbeing (ICC = 0.88, 95% CI 0.85–0.91).
Weighted kappa for individual items were all in the 
acceptable range (κ ≥ 0.4) excepting one at κ = 0.39 (I find 
some of X’s decisions about treatment difficult to accept). 
Kappa ranged from 0.39 to 0.75 with 31 items in the 
‘acceptable’ range (0.4 ≤ κ ≤ 0.59) and 9 in the ‘good’ range 
(κ ≥ 0.6).
Responsiveness to change
We have calculated responsiveness to change using two 
methods. First, we have prorated total CRSS scores for those 
participants who missed one item or more at baseline or T3. 
This maximises the number of participants included in the 
analysis and prorating, if anything, will dull responsiveness 
to change. As some experts may query prorating in a valida-
tion study, we have also analysed the data excluding those 
with any missing item at either time point. The median num-
ber of days between baseline and T3 was 66 (range 56–103).
Using prorated total CRRS scores, N = 208. Participants 
were categorised as improved, worsened or unchanged on 
WHOQOL-BREF using an effect size of 0.2 as a minimum 
threshold for significant change. Twenty-six percent were 
categorised as ‘unchanged’, 25% as ‘improved’ and 49% as 
‘worsened’. Participants who showed meaningful decline on 
WHOQOL-BREF also showed significant decline on CRRS 
scores (p < 0.001). Those who improved showed significant 
improvement on CRRS (p = 0.001). CRRS scores did not 
change significantly for those categorised as unchanged on 
WHOQOL-BREF (p = 0.196). Using a more conservative 
effect size of 0.5 as a threshold for change, 65.5% were cat-
egorised as ‘unchanged’, 26.5% as ‘worsened’ and 8% as 
‘improved’. Participants categorised as worsened showed 
significant decline on CRRS scores (p < 0.001). Those cat-
egorised as improved showed significant improvement on 
CRRS (p = 0.001). CRRS scores did not change significantly 
for participants categorised as unchanged (p = 0.288).
Including only participants who had answered all 
items on the scale, N = 171. The pattern of results was 
very similar using the 0.2 effect size for change on WHO-
QOL-BREF: 25% were categorised as unchanged; 26% 
improved and 49% worsened with those showing mean-
ingful decline also showing significant decline on CRRS 
scores (p < 0.001), those who improved showed signifi-
cant improvement on CRRS (p = 0.003) and no significant 
change in CRRS scores for those categorised as unchanged 
on WHOQOL-BREF (p = 0.371). Using the effect size of 
0.5 as a threshold for change, 64% were categorised as 
‘unchanged’, 27% as ‘worsened’ and 9% as ‘improved’. As 
Table 1  (continued) a Ethnicity is not reported as 94% of participants identified as White British
b The question relating to education was posed differently in study 3 (highest level of education, one choice 
only including professional qualifications) and study 4 (education and professional/ vocational qualifica-
tions reported separately)
Table 2  Standalone items
Item Inter-item 
correlation 
range
Median/mode |z-score skew| % Floor 
(score 
0)
% 
Ceiling 
(score 4)
Weighted κ
I am less able to fulfil my other caregiving responsibilities 
(e.g. looking after children, grandchildren, another adult, 
pets)
0.01–0.29 4/4 10.16 2 63 0.43
I worry about the impact of X’s illness on my children and/or 
other family members
0.008–0.31 1/1 1.86 24 9 0.56
I find comfort in my faith or spiritual beliefs 0.002–0.24 0/0 10.27 63 7 0.75
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Table 3  Item factor loadings
Factor loadings < 0.4 are suppressed, unless an item does not load at > 0.4 on any factor. The highest factor loading is then shown in italics
a The item CH2 loads equally on Factors 5 and 3. This item has been retained in Factor 5 (and the associated subscale self-care) as this is where 
it has most face validity
Item Factor 1
Emotional 
health and 
wellbeing
Factor 2
Sup-
port and 
impact
Factor 3
Lifestyle
Factor 4
Financial 
wellbe-
ing
Factor 5
Self-care
CH8 I feel depressed by the situation 0.77
GE1 I feel sad 0.77
CH6 I feel angry about the situation 0.73
CO8 I find it hard to think about my own future 0.73
CO10 I feel angry that our plans for the future have changed because of X’s 
illness
0.71
CO6 It is difficult to think about anything other than X’s illness 0.69
CH7 I feel overwhelmed by the situation 0.66
CH11 I feel resentful that my life has changed because of X’s illness 0.50
CR3 I find some of X’s decisions about treatment difficult to accept 0.38
CS56 Friends and family provide emotional support 0.86
CS22 Friends and family provide practical support 0.81
CS24 People are interested in how I am coping 0.74
CS55 My family and I support each other 0.71
CS21 I feel the cancer team recognise the impact on me 0.54
CS53 I feel that support is available from the health system 0.53
CO1 I keep to my normal routines and activities 0.76
CO2 I socialise less because of my caregiving responsibilities 0.74
CS2 I have taken on some of X’s responsibilities at home (e.g. cooking, clean-
ing, gardening, DIY)
0.72
GF6 I am enjoying the things I usually do for fun 0.62
CO4 I make time to do things for myself 0.58
CH4 My physical health has suffered as a result of the situation 0.53
CO7 My caregiving responsibilities are a burden 0.52
CO9 I feel as if my life is on hold 0.50
GF7 I am content with the quality of my life right now 0.42
CO5 I feel guilty taking time for myself 0.34
CH5 My mental health has suffered as a result of the situation 0.33
CF4 I have difficulty meeting the additional costs of supporting X 0.66
FT11 I feel in control of my financial situation 0.61
FT3 I worry about the financial problems I will have in the future as a result of 
X’s illness or treatment
0.61
CF3 The additional costs of supporting X are more than I thought they would 
be (e.g. travel and parking, heating, healthy eating, supplements, non-
prescription medication, paying for help at home)
0.55
CF2 I have to help X financially as a result of his/her illness 0.50
CF1 I know where to access financial advice and support 0.41
CH9 I feel confident in my ability to support X 0.63
CR4 X and I speak openly with each other about his/her illness 0.60
CH3 I look after myself emotionally 0.51
CR6 I protect myself by not talking about X’s illness 0.42
CH1 I have a positive attitude to life 0.39
CH2 I look after myself  physicallya 0.37 0.37
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before those who showed meaningful decline or improve-
ment also showed significant decline or improvement on 
the CRRS (p < 0.001 and p = 0.003 respectively). CRRS 
scores did not change significantly for those categorised as 
unchanged (p = 0.496). Table 5 shows mean CRRS change 
by group for both analyses.
As predicted, CRRS change scores correlated signifi-
cantly with change on CQOLC and WHOQOL-BREF 
whether using prorated CRRS scores (N = 209, r = 0.62; 
N = 208 r = 0.53 respectively) or only including partici-
pants with complete CRRS data (N = 173, r = 0.65; N = 171 
r = 0.56 respectively).
Table 4  Inter-item correlations and correlation between subscale scores
Subscale Mean (SD)
Range
Inter-item 
correlation 
range
Correlations between subscale scores
Emotional 
health and 
wellbeing
Lifestyle Support and impact Self-care Financial 
wellbe-
ing
Emotional Health and Wellbeing (9 
items, possible score 0–36)
25.14 (7.65)
3–36
N = 241
0.14 to 0.65
29/36 r > 0.3
N = 241
1.00
Lifestyle (11 items, possible score 0–44) 29.03 (8.49)
5–44
N = 237
0.22 to 0.60
45/55 r > 0.3
N = 237
0.62
N = 235
1.00
Support and Impact (6 items, possible 
score 0–24)
13.65 (5.47)
2–24
N = 237
0.22 to 0.65
12/15 r > 0.3
N = 237
0.17
N = 235
0.19
N = 230
1.00
Self-care (6 items, possible score 0–24) 18.02 (3.98)
4–24
N = 243
0.14 to 0.68
6/15 r > 0.3
N = 243
0.52
N = 240
0.48
N = 237
0.35
N = 235
1.00
Financial Wellbeing (6 items, possible 
score 0–24)
17.76 (5.02)
4–24
N = 242
0.12 to 0.59
10/15 r > 0.3
N = 242
0.50
N = 240
0.52
N = 235
0.22
N = 236
0.36
N = 240
1.00
Table 5  CRRS change by 
change on WHOQOL-BREF
a |Mean change score|∕SDmean baseline score
WHOQOL-BREF N Baseline CRRS 
mean (SD)
Mean CRRS change (SD) p Effect  sizea
 Using prorated CRRS scores if missing data presentN = 208
 0.2 effect size
  Improved 52 108.60 (25.00) − 5.62 (11.16) 0.001 0.22
  Unchanged 55 110.78 (20.84) 2.32 (13.13) 0.196 0.11
  Worsened 101 109.62 (22.11) 7.75 (12.13) < 0.001 0.35
 0.5 effect size
  Improved 17 98.75 (31.20) − 12.04 (12.79) 0.001 0.39
  Unchanged 136 110.14 (21.33) 1.05 (11.52) 0.288 0.05
  Worsened 55 111.89 (21.53) 12.35 (11.25) < 0.001 0.57
Using only participants with complete CRRS dataN = 171
 0.2 effect size
  Improved 44 109.57 (26.14) − 5.52 (11.64) 0.003 0.21
  Unchanged 43 112.09 (21.33) 1.58 (11.48) 0.371 0.07
  Worsened 84 107.31 (22.18) 8.18 (12.90) < 0.001 0.37
 0.5 effect size
  Improved 15 101.40 (32.38) − 12.60 (13.53) 0.003 0.39
  Unchanged 110 109.93 (22.27) 0.71 (10.89) 0.496 0.03
  Worsened 46 109.61 (21.21) 13.54 (11.43) < 0.001 0.64
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CRRS jobs and career scale
The Jobs and Career Scale was completed by 128, 113 and 
109 caregivers at the different time points respectively. 
Table 6 shows baseline summary statistics for the items 
that make up the scale. Most of the items were skewed with 
respondents rating excellent Quality of Life; 2 had ceil-
ing effects greater than 70%. Internal consistency did not 
reach an acceptable level at baseline (α = 0.62, corrected 
item-total correlation range 0.07–0.51), T2 (α = 0.58 CITC 
range 0.01–0.49) or T3 (α = 0.61 CITC range 0.17–0.49). 
Test–retest reliability was robust however: weighted Kappa 
ranged from 0.45 to 0.73; ICC for subscale total was 0.79 
(95% CI 0.71–0.85).
Discussion
The CRRS was developed as a self-report instrument for 
informal caregivers. Informed by concept mapping of cur-
rent PRO content, it was developed through extensive quali-
tative work to address the identified neglected areas. It is a 
comprehensive measure providing a profile of five subscales: 
Emotional Health and Wellbeing, Lifestyle, Support and 
Impact, Self-Care and Financial Wellbeing. The standalone 
subscale, Jobs and Careers is completed only by participants 
currently in paid employment. The format and structure are 
compatible with the FACIT Measurement System. Devel-
oped initially with the informal caregivers of people with 
advanced cancer, it is nevertheless sufficiently generic for 
use in early stage cancer and with other chronic conditions.
Our method of recruiting caregivers for all of the 
PROACT studies was to have patients nominate their pri-
mary informal caregiver. Defined as ‘the person who is 
your main source of support’, caregivers could be provid-
ing emotional and/or practical support, such as attending 
appointments, not necessarily more personal care tasks. 
Thus some participants might have been providing emo-
tional support every few days by telephone, while others 
would be engaged in personal care such as help with dress-
ing or washing. While the cancer stage is important, so is the 
level of caregiving that is provided, and this varied within 
both early and advanced groups. For example, a patient with 
early stage cancer may need considerable support in many 
aspects of life immediately after surgery and during treat-
ment, while someone who had surgery for grade III mela-
noma some years previously and is currently only having 
regular scans may need relatively little support. Because the 
questionnaires have been developed and validated in such a 
range of caregivers, we feel confident that the items included 
are relevant and important at any level of caregiving and can 
provide a useful measure over time if the trajectory changes. 
Furthermore, the very low rate of missing data in study 4 Ta
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leads us to believe that the items are acceptable, appropriate 
and possible to answer for caregivers to patients with early 
stage cancer.
The CRRS appears to be acceptable to participants both 
in terms of time to complete and the very low missing data 
rate in total and per item. Missing data were notably higher 
for three items, which have been excluded from the EFA and 
any subscale scores. No participants recorded minimum or 
maximum scores on the final scale.
The inclusion of a total score as well as a profile of sub-
scale scores is a topic of discussion. We believe there is util-
ity in a total score, particularly when the scale is being used 
as part of a clinical discussion for straightforward monitor-
ing of global change over time and as a way to alert both 
the caregiver and healthcare professional that they may be 
experiencing difficulties and may benefit from further dis-
cussion and/or investigation. That said, some caution may 
be warranted in the use of a total score as the correlation 
between ‘emotional health and wellbeing’ and ‘lifestyle’ 
subscale scores is quite high (r = 0.62) and there is a risk 
these factors might dominate the score.
The 41 core items yield a total score and 5 subscale 
scores. All demonstrated good internal consistency and 
test–retest reliability. The total score can be calculated using 
all 41 items or excluding the three standalone items, either 
score showed the predicted strength of correlation with 
measures for criterion and convergent validity. The scale 
demonstrated responsiveness to change. Whether a thresh-
old effect size of 0.2 or a more conservative 0.5 was used, 
caregivers showing improvement on the anchor variable 
showed significant improvement in CRRS scores and those 
declining on the anchor variable showed significant decline 
in CRRS scores.
We did not make any a priori hypotheses on group dif-
ferences on either the total or separate subscale scores. 
We found that age was a significant factor with significant 
post-hoc contrasts between those over 65 years and those 
aged 51–65, and those over 65 years and those 50 years or 
younger. Retired caregivers had significantly higher scores 
than those working and those not in paid employment. 
Those working had significantly higher scores than those 
not in paid employment. Caregivers who had given up work 
because of their caregiving responsibilities had significantly 
lower scores than those who had not (either because they 
were not working or had continued to work) and those car-
ing for someone currently on treatment, significantly lower 
than those caring for someone not receiving treatment. There 
was no difference in scores for those who had additional 
caregiving responsibilities, such as for children or grand-
children, and those who did not, although previous research 
suggests that the impact for caregivers is likely to be related 
to the number of other social roles they fulfil [3]. Further 
exploration of these potential cumulative effects and the role 
of age and employment will be performed at a later date.
The instrument had good validity and reliability over-
all but there were features of the data that warrant caution. 
Although not displaying ceiling effects, the total score is 
negatively skewed. The Financial Wellbeing subscale is par-
ticularly skewed with 10% (still below our cut-off threshold) 
of participants having maximum score. This may reflect the 
fact that UK patients do not pay for medical treatment and 
that a large proportion of our sample were already retired 
so the financial implications due to loss of employment for 
example are less pronounced.
While internal consistency and test–retest reliability for 
the subscales is good, in some cases the corrected item-total 
and inter-item correlations are lower than 0.5 and 0.3 respec-
tively raising the question that some items may not be con-
tributing significantly to the subscales and the data might 
benefit from further item level analysis. Similarly while the 
test–retest reliability for the Jobs and Careers subscale and 
individual items was good; internal consistency for this scale 
was disappointing and warrants further investigation.
Limitations and future research
We developed the measure in caregivers to people with stage 
III/IV cancer and in a limited number of tumour groups 
which although chosen to ensure a spread of key patient 
characteristics such as age, inevitably resulted in some 
sampling bias. Additionally while a majority (80.5%) of 
UK population are White British, 94% of our participants 
described themselves as this. Cultural validity needs to be 
established as informal caregiving and the expectations on 
family members are perceived differently across cultures.
We invited patients to nominate the person who they felt 
was their main source of support. This resulted in a limited 
range of relationship ‘types’ between patient and caregiver; 
78% of caregivers were the partner or spouse of the patient. 
This means we are unable to make meaningful comparisons 
between different types of relationship, but reflects the pat-
tern of support in this group of patients.
In this study we measured change in PRO scores over 
time but have not explicitly linked these to marked changes 
in trajectory such as transition to palliative care or from 
diagnosis through treatment. This is an avenue for future 
research as caregiving responsibilities are likely to vary in 
line with different lines of treatment [9]. Furthermore, Girgis 
et al. [27] report that caregiver unmet needs shift from can-
cer care-related needs towards their own needs with increas-
ing time since diagnosis. In the current study there were 
no differences in CRRS total score by time since diagnosis 
(less than a year, 1–2 years or more than 2 years), however a 
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more detailed analysis of responses to items which are more 
cancer-care centred versus those which are more caregiver 
centred may be valuable to explore any difference over time.
The CRRS is comprehensive. Future work will examine 
which items are most descriptive of the underlying dimen-
sions. Using IRT methods we will investigate the possibility 
of reducing the number of items or producing useful short 
forms.
Conclusion
The importance of considering the needs of caregivers as 
well as patients is recognised for the provision of good care 
[28, 29].The use of PROs for caregivers alongside those for 
patients might facilitate discussions about potential treat-
ments and supportive interventions needed for both. There 
has been an increase in the development of services for 
caregivers, [30, 31] now there is need for robust measures 
to quantify the effectiveness of any such intervention. The 
CRRS and its subscale scores may provide useful indications 
as to how different domains are impacted for different indi-
viduals, allowing for a more tailored approach to supportive 
interventions [32]. This initial validation suggests that the 
CRRS shows promise. Further work, including item level 
analysis is being conducted.
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